We are live on
!
Find out more
NICM
Neo Ivy Capital Management Portfolio holdings
AUM
$379M
1-Year Est. Return
28.34%
This Fund
S&P 500
This Quarter
Est. Return
+18.75%
1 Year Est. Return
+28.34%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$87.2M
AUM Growth
+$25.8M
(+42%)
Cap. Flow
+$18.4M
Cap. Flow
% of AUM
21.14%
Top 10 Holdings %
Top 10 Hldgs %
9.07%
Holding
666
New
217
Increased
117
Reduced
105
Closed
226
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$883K |
| 2 |
L3Harris
LHX
|
+$877K |
| 3 |
Johnson & Johnson
JNJ
|
+$836K |
| 4 |
Intel
INTC
|
+$803K |
| 5 |
Prudential Financial
PRU
|
+$759K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Entergy
ETR
|
+$563K |
| 2 |
Costco
COST
|
+$557K |
| 3 |
Cintas
CTAS
|
+$506K |
| 4 |
Thermo Fisher Scientific
TMO
|
+$503K |
| 5 |
Alaska Air
ALK
|
+$476K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.61% |
| 2 | Financials | 17.3% |
| 3 | Industrials | 15.25% |
| 4 | Healthcare | 15.11% |
| 5 | Consumer Discretionary | 9.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Prologis
PLD
$132B
| $117K | 0.13% |
+1,257
| New | +$112K |
|
|
MNTA
227
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $116K | 0.13% |
3,497
-6,676
| -66% | -$213K |
|
228
DaVita
DVA
$11.5B
| $115K | 0.13% |
1,452
+1,194
| +463% | +$93.2K |
|
|
PBCT
229
DELISTED
People's United Financial Inc
PBCT
| $115K | 0.13% |
+9,947
| New | +$116K |
|
230
EOG Resources
EOG
$75B
| $114K | 0.13% |
2,251
-1,020
| -31% | -$49.4K |
|
231
Broadcom
AVGO
$1.99T
| $113K | 0.13% |
3,590
+2,650
| +282% | +$74.2K |
|
232
International Flavors & Fragrances
IFF
$21.8B
| $113K | 0.13% |
924
+757
| +453% | +$95.7K |
|
233
Avery Dennison
AVY
$13.6B
| $109K | 0.13% |
+959
| New | +$105K |
|
234
AvalonBay Communities
AVB
$26.1B
| $108K | 0.12% |
+699
| New | +$111K |
|
235
Iron Mountain
IRM
$36.5B
| $108K | 0.12% |
4,155
+236
| +6% | +$5.96K |
|
|
EXAS
236
DELISTED
Exact Sciences
EXAS
| $107K | 0.12% |
+1,229
| New | +$98.2K |
|
237
Flowserve
FLS
$10.2B
| $107K | 0.12% |
3,754
-2,832
| -43% | -$75.6K |
|
238
Tapestry
TPR
$32.9B
| $107K | 0.12% |
+8,049
| New | +$114K |
|
239
Papa John's
PZZA
$796M
| $105K | 0.12% |
+1,324
| New | +$98.5K |
|
240
Viavi Solutions
VIAV
$9.47B
| $104K | 0.12% |
8,188
-18,299
| -69% | -$219K |
|
|
FITB
241
Fifth Third Bancorp
FITB
$52.2B
| $103K | 0.12% |
+5,365
| New | +$99.4K |
|
242
American Tower
AMT
$79.7B
| $102K | 0.12% |
395
-273
| -41% | -$67.5K |
|
243
IDEX
IEX
$17.4B
| $102K | 0.12% |
+646
| New | +$98.7K |
|
244
SLM Corp
SLM
$5.16B
| $101K | 0.12% |
+14,381
| New | +$107K |
|
245
TG Therapeutics
TGTX
$7.6B
| $101K | 0.12% |
+5,209
| New | +$83.9K |
|
246
Capri Holdings
CPRI
$1.78B
| $100K | 0.11% |
6,387
-4,688
| -42% | -$69.4K |
|
247
Sabra Healthcare REIT
SBRA
$5.11B
| $100K | 0.11% |
6,937
+5,099
| +277% | +$67K |
|
|
WBA
248
DELISTED
Walgreens Boots Alliance
WBA
| $99K | 0.11% |
2,327
-1,665
| -42% | -$70.7K |
|
|
HR
249
DELISTED
Healthcare Realty Trust Incorporated
HR
| $99K | 0.11% |
+3,382
| New | +$101K |
|
250
Eastman Chemical
EMN
$8.55B
| $97K | 0.11% |
1,398
-5,768
| -80% | -$363K |
|
Similar funds
MC
ACA
AFCM
DAL
SFWC
WAM
FP
C
Neo Ivy Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Neo Ivy Capital Management held 666 positions worth $87.2M, up 42% from $61.4M the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Neo Ivy Capital Management deployed $18.4M of net new capital in Q2 2020, opening 217 new positions and adding to 117 existing holdings. Its largest new stake was Pfizer: 26,000 shares worth $807K.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Cintas, an estimated $506K trimmed.
- Neo Ivy Capital Management's largest Q2 2020 buy was Pfizer: 26,000 shares worth $807K.
- Neo Ivy Capital Management added most to CME Group in Q2 2020, an estimated $750K increase.
- Neo Ivy Capital Management's biggest Q2 2020 reduction was Cintas, cutting an estimated $506K.
- Neo Ivy Capital Management fully exited Entergy in Q2 2020, selling an estimated $563K.
- Neo Ivy Capital Management's ten largest holdings make up 9.1% of its $87.2M portfolio in Q2 2020.
- Neo Ivy Capital Management opened 217 new positions and closed 226 in Q2 2020.
- Neo Ivy Capital Management's portfolio value rose 42% quarter-over-quarter to $87.2M.
Based on Neo Ivy Capital Management's 13F filing for Q2 2020, filed 17 Aug 2020.